![Thomas Luke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Luke is currently the Deputy Director-Population Health at the Bureau of Medicine & Surgery and the Chief Medical Officer at SAB Sciences, Inc. He was previously the Chief Medical Officer at Big Cypress Acquisition Corp.
and SAB Biotherapeutics, Inc. from 2021 to 2022.
Dr. Luke has an undergraduate degree from Webster University and a doctorate from the Uniformed Services University of the Health Sciences.
| Unternehmen | Position | Beginn |
|---|---|---|
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Bureau of Medicine & Surgery
 Bureau of Medicine & Surgery Medical/Nursing ServicesHealth Services Operates medical clinics and offices of physicians | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 06.06.2022 |
| BIG CYPR | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
Webster University
 Webster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uniformed Services University of the Health Sciences
 Uniformed Services University of the Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bureau of Medicine & Surgery
Bureau of Medicine & Surgery Medical/Nursing ServicesHealth Services Operates medical clinics and offices of physicians | Health Services |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Health Technology |
Big Cypress Acquisition Corp.
 Big Cypress Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
